top of page

Who We Are

Pioneering Cancer Treatment with
Dye Drug Conjugates.

Lahjavida has developed a novel drug delivery platform called a Dye Drug Conjugate (DDC). This technology enhances cancer treatments by precisely targeting tumors while protecting healthy tissues. Dye Drug Conjugates remain non-toxic during circulation and activate only when they reach cancer cells, ensuring focused treatment.

Discover Lahjavida.

AdobeStock_705051370.jpeg
pexels-ivan-samkov-6436252.jpg

Innovation and Expertise in Dye and Molecular Design.

With 25 years of expertise in tumor-targeting dye technology, Lahjavida is pioneering a new approach.

 

Our Dye Drug Conjugate platform uses a tumor-targeting dye to deliver chemotherapy directly to cancer cells, minimizing harm to healthy tissues. This groundbreaking approach combines proven tumor-targeting dye technology with chemotherapy drug efficacy. 

Ocean

Our Technology
Learn more about the results of our Dye Drug Conjugates

bottom of page